These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7763065)

  • 21. [Infectious complications of implantable infusion ports in patients with HIV infection].
    Benharrats I; Trivalle C; Sahraoui K; Rabian C; Sicard JF; Delzant G
    Rev Med Interne; 1997; 18(6):443-9. PubMed ID: 9247043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A totally implanted venous access system used in pediatric patients with cancer.
    Shulman RJ; Rahman S; Mahoney D; Pokorny WJ; Bloss R
    J Clin Oncol; 1987 Jan; 5(1):137-40. PubMed ID: 3806156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complications of indwelling venous access lines in the pediatric hematology patient: a prospective comparison of external venous catheters and subcutaneous ports.
    Ingram J; Weitzman S; Greenberg ML; Parkin P; Filler R
    Am J Pediatr Hematol Oncol; 1991; 13(2):130-6. PubMed ID: 2069219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of indwelling central venous catheter sepsis.
    Daghistani D; Horn M; Rodriguez Z; Schoenike S; Toledano S
    Med Pediatr Oncol; 1996 Jun; 26(6):405-8. PubMed ID: 8614377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer.
    Beckers MM; Ruven HJ; Seldenrijk CA; Prins MH; Biesma DH
    Thromb Res; 2010 Apr; 125(4):318-21. PubMed ID: 19640573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central venous access devices in children with congenital coagulation disorders: complications and long-term outcome.
    McMahon C; Smith J; Khair K; Liesner R; Hann IM; Smith OP
    Br J Haematol; 2000 Aug; 110(2):461-8. PubMed ID: 10971409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of efficacy of twice-weekly urokinase in the prevention of complications associated with Hickman catheters: a multicentre randomised comparison of urokinase versus heparin.
    Solomon B; Moore J; Arthur C; Prince HM
    Eur J Cancer; 2001 Dec; 37(18):2379-84. PubMed ID: 11720831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Central venous totally implantable access for high dose chemotherapy in children].
    Conter C; Carausu L; Martin E; Rubie H; Castex MP; Marec-Berard P
    Arch Pediatr; 2006 Mar; 13(3):256-61. PubMed ID: 16469486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-lumen subcutaneous ports inserted by interventional radiologists in patients undergoing chemotherapy: incidence of infection and outcome of attempted catheter salvage.
    Kuizon D; Gordon SM; Dolmatch BL
    Arch Intern Med; 2001 Feb; 161(3):406-10. PubMed ID: 11280300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of broviac catheter infections in pediatric oncology patients.
    Johnson PR; Decker MD; Edwards KM; Schaffner W; Wright PF
    J Infect Dis; 1986 Oct; 154(4):570-8. PubMed ID: 3745971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of feasibility and acceptability of subcutaneous implantable ports (SIPs) in cancer patients.
    Mittal L; Kalra M; Mahajan A
    Indian J Pediatr; 2012 Dec; 79(12):1601-4. PubMed ID: 22374232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiologic placement of a low profile implantable venous access port in a pediatric population.
    Nosher JL; Bodner LJ; Ettinger LJ; Siegel RL; Gribbin C; Asch J; Drachtman RA
    Cardiovasc Intervent Radiol; 2001; 24(6):395-9. PubMed ID: 11907746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An experience with an implanted port system in 66 children with cancer.
    Becton DL; Kletzel M; Golladay ES; Hathaway G; Berry DH
    Cancer; 1988 Jan; 61(2):376-8. PubMed ID: 3334972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical experience with totally implantable venous access systems in pediatric hematology and oncology].
    Maloisel F; Geiss S; Clavert JM; Amaral D; Babin-Boilletot A
    Ann Pediatr (Paris); 1993 Jun; 40(6):353-9. PubMed ID: 8352496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maintaining patency and asepsis of vascular access ports in Yucatan miniature swine.
    Henderson KK; Mokelke EA; Turk JR; Rector RS; Laughlin MH; Sturek M
    Contemp Top Lab Anim Sci; 2003 Nov; 42(6):28-32. PubMed ID: 14615957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Long-term central venous access in oncology. Review of a caseload of 750 cases].
    Bertoglio S; Meszsaros P; Disomma C; Moresco L; Cafiero F; Gipponi M; Percivale P
    Minerva Chir; 1996 Jun; 51(6):427-31. PubMed ID: 8992390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Centrally inserted external catheters and totally implantable ports for the delivery of chemotherapy: a systematic review and meta-analysis of device-related complications.
    Kulkarni S; Wu O; Kasthuri R; Moss JG
    Cardiovasc Intervent Radiol; 2014 Aug; 37(4):990-1008. PubMed ID: 24218174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Teicoplanin in gram-positive infection: microbiological aspects.
    Spencer RC
    Eur J Haematol Suppl; 1993; 54():6-9. PubMed ID: 8365463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
    Garland JS; Alex CP; Henrickson KJ; McAuliffe TL; Maki DG
    Pediatrics; 2005 Aug; 116(2):e198-205. PubMed ID: 15995005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcutaneous venous port implantation in adult patients: a single center experience.
    Cil BE; Canyiğit M; Peynircioğlu B; Hazirolan T; Carkaci S; Cekirge S; Balkanci F
    Diagn Interv Radiol; 2006 Jun; 12(2):93-8. PubMed ID: 16752357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.